What is Theravance Biopharma's other working capital?

Theravance Biopharma (TBPH) reported other working capital of -$42K in Q1 2026.

How has Theravance Biopharma's other working capital changed year-over-year?

Theravance Biopharma's other working capital decreased by 207.7% year-over-year, from $39K to -$42K.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Theravance Biopharma TBPH Other Working Capital

Other Working Capital at other companies

Zevra Therapeutics, Inc.ZVRA

$341K-48.6%

United TherapeuticsUTHR

-$27M+79.9%

Aurinia PharmaceuticalsAUPH

-$581K+75.0%

Ultragenyx PharmaceuticalRARE

-$1M-200%

OrganonOGN

-$8M+80.0%

Mirum Pharmaceuticals, Inc.MIRM

$278K-21.9%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's other working capital?: Theravance Biopharma (TBPH) reported other working capital of -$42K in Q1 2026.
How has Theravance Biopharma's other working capital changed year-over-year?: Theravance Biopharma's other working capital decreased by 207.7% year-over-year, from $39K to -$42K.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.